Generally speaking, the results of this study have led to the important conclusion that differences in PPRC1 expression in different malignant tumors seriously affect the survival time of tumor patients as PPRC1 expression is upregulated in a variety of cancers and is associated with poorer prognosis. This evidence concerns the gene PPRC1 and neoplasm.